Envista Holdings Corp. (NVST) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Envista Holdings Corp. (NVST) Healthcare & Pipeline Overview

Envista Holdings Corp. provides dental solutions, encompassing specialty products, technologies, and equipment. Operating through two segments, the company caters to dental professionals globally with a focus on diagnosing, treating, and preventing dental conditions. With a market cap of $4.21B, Envista competes in the broader medical equipment and services sector.

What Is the Investment Thesis for NVST?

Envista Holdings Corp. presents a notable research candidate within the dental equipment and supplies market. With a market capitalization of $4.21B and a P/E ratio of 43.85, the company demonstrates significant market presence. A key value driver is its diversified product portfolio across both Specialty Products & Technologies and Equipment & Consumables segments, providing revenue stability. Growth catalysts include expansion in emerging markets and continued innovation in digital dentistry solutions. The company's ongoing focus on research and development is expected to drive new product launches and maintain its competitive edge. However, potential risks include fluctuations in dental procedure volumes and increasing competition from established and emerging players. The company's beta of 0.98 indicates moderate volatility relative to the market.

Based on FMP financials and quantitative analysis

NVST Key Highlights

Market Cap of $4.21B indicates a strong market presence within the dental equipment and supplies industry.

• P/E ratio of 43.85 reflects investor expectations of future earnings growth, although it is relatively high compared to industry peers.
• Gross Margin of 55.1% demonstrates efficient cost management and pricing power in its product offerings.
• Profit Margin of 2.4% indicates room for improvement in operational efficiency and expense management.
• Beta of 0.98 suggests the stock's volatility is slightly less than the overall market, providing some stability for investors.

Who Are NVST's Competitors?

NVST is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are NVST's Key Strengths?

Comprehensive product portfolio covering various dental specialties.

• Strong brand recognition and reputation in the dental industry.
• Global presence with established distribution channels.
• Focus on innovation and digital dentistry solutions.

What Are NVST's Weaknesses?

Profit margin of 2.4% indicates potential inefficiencies.

• High P/E ratio of 43.85 suggests potential overvaluation.
• Dependence on dental procedure volumes, which can be affected by economic conditions.
• Exposure to regulatory changes and compliance requirements.

What Could Drive NVST Stock Higher?

New product launches in digital dentistry solutions expected in Q3 2026.

• Expansion of distribution network in emerging markets.
• Continued investment in research and development to drive innovation.
• Strategic acquisitions to expand product portfolio and market reach.

What Are the Key Risks for NVST?

Rich valuation — a P/E of 43.85 runs well above the Healthcare sector’s ~21.50x, leaving little room for a miss.

• Insider selling — insiders were net sellers of roughly $1.2M recently.
• Fluctuations in dental procedure volumes due to economic conditions.
• Intense competition from established and emerging players.
• Changes in reimbursement policies and healthcare regulations.
• Patent expirations and generic competition.
• Supply chain disruptions affecting manufacturing and distribution.

What Are the Growth Opportunities for NVST?

• Expansion in Emerging Markets: Envista has a significant opportunity to expand its presence in emerging markets, where dental care awareness and access are increasing. These markets, particularly in Asia-Pacific and Latin America, represent a substantial growth potential as disposable incomes rise and healthcare infrastructure improves. By tailoring its product offerings and distribution strategies to meet the specific needs of these markets, Envista can capture a larger share of the global dental market. This expansion could contribute significantly to revenue growth over the next 3-5 years.
• Innovation in Digital Dentistry: The dental industry is undergoing a digital transformation, with increasing adoption of technologies such as digital imaging, CAD/CAM systems, and 3D printing. Envista can capitalize on this trend by investing in research and development to create innovative digital dentistry solutions that improve the efficiency, accuracy, and patient experience of dental procedures. This includes developing advanced software, imaging systems, and materials that integrate seamlessly into dental practices. The market for digital dentistry is projected to grow significantly over the next decade, providing a substantial opportunity for Envista.
• Strategic Acquisitions: Envista can pursue strategic acquisitions to expand its product portfolio, geographic reach, and technological capabilities. By acquiring companies with complementary products or technologies, Envista can strengthen its competitive position and accelerate its growth. Potential acquisition targets include companies specializing in niche dental products, emerging technologies, or geographic markets where Envista has limited presence. These acquisitions can provide access to new customers, distribution channels, and intellectual property, enhancing Envista's long-term growth prospects.
• Development of Advanced Materials: The demand for advanced dental materials, such as biocompatible implants, high-strength ceramics, and aesthetic restorative materials, is increasing. Envista can invest in research and development to create innovative materials that offer superior performance, durability, and aesthetics. These materials can be used in a wide range of dental applications, including implants, crowns, bridges, and veneers. By developing and marketing advanced materials, Envista can differentiate itself from competitors and capture a larger share of the dental materials market. The market for advanced dental materials is expected to grow steadily over the next several years.
• Enhancing Customer Education and Training: Providing comprehensive education and training programs for dental professionals is crucial for driving adoption of Envista's products and technologies. Envista can invest in developing online and in-person training programs that educate dentists and dental staff on the proper use and benefits of its products. These programs can cover a wide range of topics, including implant placement, orthodontic treatment, digital dentistry workflows, and infection control protocols. By enhancing customer education and training, Envista can build stronger relationships with dental professionals and increase product sales. The investment in education and training will pay dividends in the form of increased customer loyalty and product adoption.

What Are NVST's Competitive Advantages?

• Diversified product portfolio across multiple dental segments.
• Established brand reputation and customer relationships.
• Strong research and development capabilities.
• Global distribution network.

What Does NVST Do?

Envista Holdings Corp. is a global manufacturer and marketer of dental products and technologies, dedicated to helping dental professionals improve patients' lives. Spun off from Danaher Corporation in 2019, Envista has quickly established itself as a significant player in the dental industry. Headquartered in Brea, California, the company employs approximately 12,300 individuals. Envista operates through two primary segments: Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment focuses on developing, manufacturing, and marketing dental implant systems, prosthetics, associated treatment software, orthodontic bracket systems, aligners, and lab products. This segment caters to specialized dental procedures and advanced treatment modalities. The Equipment & Consumables segment develops, manufactures, and markets a wide range of dental equipment and supplies used in dental offices. This includes digital imaging systems, software, visualization and magnification systems, treatment units, endodontic systems, restorative materials, instruments, rotary burs, impression materials, bonding agents, cements, and infection prevention products. Envista's comprehensive product portfolio allows it to serve a broad spectrum of dental professionals and address diverse patient needs, solidifying its position in the competitive dental market.

What Products and Services Does NVST Offer?

• Manufactures and markets dental implant systems.
• Provides dental prosthetics and associated treatment software.
• Offers orthodontic bracket systems and aligners.
• Develops and markets lab products for dental applications.
• Manufactures digital imaging systems and software.
• Provides treatment units and other dental practice equipment.
• Offers endodontic systems and related consumables.
• Supplies restorative materials, instruments, and infection prevention products.

How Does NVST Make Money?

• Develops and manufactures a wide range of dental products.
• Markets and sells products directly to dental professionals and through distributors.
• Generates revenue through the sale of dental equipment, consumables, and specialty products.
• Provides training and support services to customers.

What Industry Does NVST Operate In?

Envista Holdings Corp. operates in the global dental equipment and supplies market, which is characterized by steady growth driven by an aging population, increasing awareness of oral hygiene, and technological advancements in dental procedures. The market is competitive, with established players and emerging companies vying for market share. Trends include the adoption of digital dentistry solutions, such as CAD/CAM systems and 3D printing, as well as the growing popularity of cosmetic dentistry. Envista's focus on innovation and its diversified product portfolio position it well to capitalize on these trends and maintain its competitive edge. Competitors include companies offering similar dental equipment, consumables, and specialty products.

Who Are NVST's Key Customers?

• Dental professionals, including dentists, orthodontists, and oral surgeons.
• Dental laboratories.
• Hospitals and clinics.
• Dental distributors.

Envista Holdings Corp. (NVST) Valuation Context

Valued at $4.21B, NVST is classified as a mid-cap stock. Analyst price targets span from $23.00 to $34.00, with a consensus of $29.50. At the current price of $25.87, that implies approximately 14% upside potential. Relative to its peer group, NVST's quantitative score of 95/100 is above the peer average of 60/100.

NVST Revenue & Earnings Trend

In Q2 FY2026, NVST generated $730.5M in top-line revenue, marking a sequential increase of 3.5%. The company recorded net income of $53.7M, with diluted EPS of $0.33. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, NVST averaged $0.15 in diluted EPS.

Company Profile

Envista Holdings Corp. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Brea, US. The company is led by CEO Paul A. Keel. NVST has traded publicly since 2019.

Return on equity for Envista Holdings Corp. stands at 4.1%, a gauge of how efficiently it converts shareholder capital into profit. NVST trades at a trailing price-to-earnings ratio of 43.85, above the Healthcare sector average of ~21.50x. Its free cash flow yield is 5.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.43 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.0%, the inverse of the P/E and a quick read on earnings relative to price.

Envista Holdings Corp.'s Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals.

Envista Holdings Corp. has beaten Wall Street's EPS estimate in 8 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 17.7% above estimates on average.

Over the past six months, Envista Holdings Corp. insiders filed 16 SEC Form 4 transactions — 6 sales and 10 purchases. On net that is roughly 411K shares acquired (about $1.2M) — insiders putting money in tends to read as conviction.

NVST Financials

NVST Latest News

NVST Analyst Consensus

NVST MoonshotScore

What Investors Ask About Envista Holdings Corp. (NVST) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources